# FDA 483 - Robinson Pharma Inc - September 25, 2014

Source: https://www.globalkeysolutions.net/records/483/robinson-pharma-inc/b05f3735-a912-4f9a-b960-acccb1ea728e

> FDA 483 for Robinson Pharma Inc on September 25, 2014. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Robinson Pharma Inc
- Inspection Date: 2014-09-25
- Product Type: other
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Robinson Pharma Inc. in Santa Ana, CA, a dietary supplement manufacturer, was cited for significant quality control deficiencies during an FDA inspection. Observations included failing to ensure finished product conformity to specifications, inadequate documentation for product testing, and releasing batches for distribution without proper approval. These issues indicate a lack of robust quality control over product release and specification verification.

## Related Documents

- [483 - 2014-09-25](https://www.globalkeysolutions.net/records/483/robinson-pharma-inc/868db067-3902-4c92-9933-55749319fee1)
- [483 - 2017-08-30](https://www.globalkeysolutions.net/records/483/robinson-pharma-inc/ba5a688e-41ae-404c-8f14-9ba95a048bcf)
- [483 - 2017-08-30](https://www.globalkeysolutions.net/records/483/robinson-pharma-inc/520055a7-d707-43e2-aa24-11ee64f8a2d8)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/trushani-t-desai/d432975f-0b06-4bb6-8b62-54162192d5ab)

Company: https://www.globalkeysolutions.net/companies/robinson-pharma-inc/2c89f954-9e61-4c8f-919a-595be7142b68

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6